PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Internal Medicine10.3904/kjim.2016.4292018331228-229Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims databaseJi-Won Kim, Sang Gyu Kwak, Sung-Hoon Parkhttp://kjim.org/upload/kjim-2016-429.pdf, http://kjim.org/journal/view.php?doi=10.3904/kjim.2016.429, http://kjim.org/upload/kjim-2016-429.pdf
Value in Health10.1016/j.jval.2012.03.2722012154A49PMS83 Adherence and Uric Acid Goal Attainment with Urate Lowering Therapy in Patients with GoutN. Rashid, C.T. Cheetham, F. Niuhttp://api.elsevier.com/content/article/PII:S1098301512003373?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S1098301512003373?httpAccept=text/plain
The Korean Journal of Internal Medicine10.3904/kjim.2006.21.2.89200621289Effect of Fenofibrate in Combination with Urate Lowering Agents in Patients with GoutYou-Hyun Lee, Chan-Hee Lee, Jisoo Leehttp://synapse.koreamed.org/pdf/10.3904/kjim.2006.21.2.89, http://synapse.koreamed.org/DOIx.php?id=10.3904/kjim.2006.21.2.89
Value in Health10.1016/j.jval.2015.03.9022015183A155Long-Term Decrease In Gout Flare Rates Associated With Effective Urate Lowering TherapyK. Keltonhttp://api.elsevier.com/content/article/PII:S1098301515009596?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S1098301515009596?httpAccept=text/plain
BMC Musculoskeletal Disorders10.1186/1471-2474-13-1742012131Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in goutNicola Dalbeth, Meaghan E House, Anne Horne, Keith J Petrie, Fiona M McQueen, William J Taylorhttp://link.springer.com/content/pdf/10.1186/1471-2474-13-174.pdf, http://link.springer.com/article/10.1186/1471-2474-13-174/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2474-13-174
Joint Bone Spine10.1016/j.jbspin.2015.02.0212015826428-431Significance of the initiation time of urate-lowering therapy in gout patients: A retrospective researchXin Feng, Yao Li, Wei Gaohttp://api.elsevier.com/content/article/PII:S1297319X15001682?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S1297319X15001682?httpAccept=text/plain
Nature Reviews Rheumatology10.1038/nrrheum.2013.120201399506-506Intensive urate-lowering therapy improves structural joint damage in patients with tophaceous goutJenny Bucklandhttp://www.nature.com/articles/nrrheum.2013.120.pdf, http://www.nature.com/articles/nrrheum.2013.120, http://www.nature.com/articles/nrrheum.2013.120.pdf
Patient Preference and Adherence10.2147/ppa.s979272017Volume 11795-800Treatment approaches and adherence to urate-lowering therapy for patients with goutThanda Aung, Gihyun Myung, John FitzGeraldhttps://www.dovepress.com/getfile.php?fileID=36092, https://www.dovepress.com/getfile.php?fileID=36092
Value in Health10.1016/j.jval.2011.02.7012011143A125-A126PMS16 COST OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TNF-ANTAGONIST THERAPY FROM THE KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASES.J. Park, E.K. Leehttp://api.elsevier.com/content/article/PII:S1098301511008400?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S1098301511008400?httpAccept=text/plain
Arthritis Care & Research10.1002/acr.22059201366182-85Exploratory Study of Radiographic Change in Patients With Tophaceous Gout Treated With Intensive Urate-Lowering TherapyNicola Dalbeth, Anthony J. Doyle, Fiona M. McQueen, John Sundy, Herbert S. B. Barafhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.22059